4005 住友化学

時価

5532億円

PER 予

27.32倍

2010年以降

赤字-137.94倍
（2010-2024年）

0.57倍

2010年以降

0.46-1.77倍
（2010-2024年）

2.69%

ROE 予

2.07%

ROA 予

0.51%

Other Financial AssetsCAIFRS、Other ProvisionCL、Capital Expenditures Overview Of Capital Expenditures Etc - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member他2件

【期間】

年度	Other Financial AssetsCAIFRS		Other ProvisionCL		Capital Expenditures Overview Of Capital Expenditures Etc - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member		外部収益 - 医薬品		Total Changes Of Items During The PeriodMI
2018/09	-		-		-		2427億		-
2019/09	-		-		-		2474億	+2%	-
2020/09	-		-		-		2761億	+11.6%	-
2021/09	-		-		-		3096億	+12.1%	-
2022/09	-		-		-		3344億	+8%	-
2023/09	-		-		-		1669億	-50.1%	-

2018年9月

Other Financial AssetsCAIFRS: -
Other ProvisionCL: -
Capital Expenditures Overview Of Capital Expenditures Etc - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
外部収益 - 医薬品: 2427億
Total Changes Of Items During The PeriodMI: -

2019年9月

Other Financial AssetsCAIFRS: -
Other ProvisionCL: -
Capital Expenditures Overview Of Capital Expenditures Etc - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
外部収益 - 医薬品: 2474億4600万
Total Changes Of Items During The PeriodMI: -

2020年9月

Other Financial AssetsCAIFRS: -
Other ProvisionCL: -
Capital Expenditures Overview Of Capital Expenditures Etc - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
外部収益 - 医薬品: 2761億4100万
Total Changes Of Items During The PeriodMI: -

2021年9月

Other Financial AssetsCAIFRS: -
Other ProvisionCL: -
Capital Expenditures Overview Of Capital Expenditures Etc - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
外部収益 - 医薬品: 3095億8000万
Total Changes Of Items During The PeriodMI: -

2022年9月

Other Financial AssetsCAIFRS: -
Other ProvisionCL: -
Capital Expenditures Overview Of Capital Expenditures Etc - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
外部収益 - 医薬品: 3344億4500万
Total Changes Of Items During The PeriodMI: -

2023年9月

Other Financial AssetsCAIFRS: -
Other ProvisionCL: -
Capital Expenditures Overview Of Capital Expenditures Etc - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
外部収益 - 医薬品: 1669億2700万
Total Changes Of Items During The PeriodMI: -